Razelle Kurzrock, Founding Director at Michels Rare Cancers Research Laboratories at Medical College of Wisconsin, shared a post on X:
“An abundance of riches. The number of anti-PD1 and anti-PDL1 agents keeps growing.
And they are amazing drugs.
Occasional they even cure refractory very advanced metastatic disease.”
More posts featuring Cancer Treatment.